Coping and Self-Efficacy Mediate Mood Improvements in Brain Tumor Caregivers

Mitigating the Psychological Burden of Neuro-Oncology Caregiving

Caregivers of patients with primary malignant brain tumors manage a unique constellation of clinical challenges, including the rapid cognitive and physical decline of their loved ones [1, 2]. The psychological burden in this population is substantial, with nearly 40% to 48% of caregivers experiencing clinically significant symptoms of anxiety and depression [3]. Despite the devastating impact of these tumors on the family unit, evidence-based supportive care resources tailored specifically to the neuro-oncology setting have historically been limited [4, 3]. While data from a randomized controlled trial of 120 caregivers demonstrate that a six-session telehealth intervention can significantly reduce anxiety (p = 0.008) and depression (p = 0.004), the specific mechanisms driving these improvements require further investigation [5, 4]. A recent secondary analysis now examines the specific psychological pathways, such as improved coping ability (a mediator accounting for 75% of the total intervention effect on anxiety), through which this targeted intervention exerts its therapeutic effects [6, 7].

Telehealth Intervention for Glioblastoma Caregivers

The study analyzed data from 120 caregivers of patients diagnosed with primary malignant brain tumors to evaluate the mechanisms behind psychological symptom relief. The sample had a mean age of 53 years and was predominantly composed of participants who self-identified as female (82.5%) and White (91.7%). The clinical burden on this group was high, as 84% of participants were caring for a patient with glioblastoma, a diagnosis associated with rapid functional decline and high caregiver distress. Furthermore, 70.0% of the participants were spouses or partners of the patients, representing a population with deep emotional and domestic ties to the care recipient. Participants were randomized to receive either usual care or NeuroCARE, a six-session, cognitive-behavioral, telehealth intervention. This structured program was designed to provide psychological support remotely, bypassing the logistical challenges of in-person visits for families managing high-acuity neurological disease. To understand how the intervention worked, the researchers conducted four simple mediation regression models using the Preacher and Hayes bootstrapping method. This statistical approach identifies whether the treatment effect is transmitted through an intermediate variable (a mediator), such as a change in the caregiver's psychological skills, rather than the treatment acting directly on the outcome. The findings indicate that the reduction in 11-week anxiety symptoms among those in the NeuroCARE group was significantly mediated by improved coping (indirect effect = -1.44, SE = 0.49, 95% CI [-2.50, -0.54]) and self-efficacy (indirect effect = -1.29, SE = 0.42, 95% CI [-2.16, -0.52]), which refers to a caregiver's confidence in their ability to manage cancer-related challenges. Similarly, improvements in 11-week depression symptoms were mediated by both coping (indirect effect = -1.43, SE = 0.38, 95% CI [-2.21, -0.74]) and self-efficacy (indirect effect = -0.95, SE = 0.32, 95% CI [-1.60, -0.36]). These data suggest that the intervention successfully mitigates mood disturbances by systematically enhancing the specific psychological resources caregivers need to navigate the complexities of neuro-oncological care.

Quantifying Psychological Mediators and Clinical Outcomes

To evaluate the psychological impact of the NeuroCARE intervention, the researchers utilized a structured assessment timeline, collecting data at baseline, 11 weeks, and 16 weeks. They measured anxiety and depression symptoms using the Hospital Anxiety and Depression Scale, a validated tool for identifying emotional distress in clinical populations. To understand the mechanisms of change, the study also tracked specific psychological resources. Coping was assessed using the Measure of Current Status, a tool that evaluates an individual's ability to manage stressors and utilize relaxation techniques. Additionally, the researchers employed the Lewis Cancer Self-Efficacy Scale, which is a metric measuring a person's confidence in their ability to manage the various challenges of a cancer diagnosis. The study explored whether intervention effects were mediated by improvements in coping and self-efficacy, seeking to identify the specific drivers of symptom relief. To achieve this, the researchers conducted four simple mediation regression models using the Preacher and Hayes bootstrapping method. This statistical technique is used to determine if the effect of an intervention is transmitted through an intermediate variable, providing a more granular view of how behavioral therapy influences clinical outcomes. These models specifically examined whether improvements in coping or self-efficacy from baseline to 11 weeks mediated intervention effects on 11-week anxiety or depression symptoms. By isolating these pathways, the analysis demonstrated that the intervention's efficacy was tied to measurable gains in the caregivers' internal psychological management strategies.

Mechanisms of Anxiety and Depression Reduction

The primary analysis of the trial demonstrated that caregivers receiving NeuroCARE demonstrated improved anxiety and depression symptoms at 11 weeks post-randomization compared to those in usual care. This clinical improvement was not merely a direct result of the telehealth sessions but was driven by specific changes in how caregivers managed their psychological burden. By analyzing the pathways of change, the researchers identified that the reduction in emotional distress was statistically explained by gains in internal resources. These findings suggest that the NeuroCARE intervention improves mood by enhancing coping skills and improving caregivers’ self-efficacy, providing clinicians with a clear target for psychological support in neuro-oncology settings. For the management of anxiety, the study found that the success of the intervention was heavily dependent on the development of better adaptive strategies. Improved coping mediated 11-week anxiety symptoms with an indirect effect of -1.44 (SE = 0.49, 95% CI [-2.50, -0.54]). Furthermore, the caregivers' confidence in their ability to handle the demands of the illness played a critical role. Improved self-efficacy mediated 11-week anxiety symptoms with an indirect effect of -1.29 (SE = 0.42, 95% CI [-2.16, -0.52]). These values indicate that as caregivers gained specific skills and confidence, their clinical anxiety scores decreased accordingly. Similar mechanisms were observed in the reduction of depressive symptoms. The analysis showed that improved coping mediated 11-week depression symptoms with an indirect effect of -1.43 (SE = 0.38, 95% CI [-2.21, -0.74]). Additionally, the sense of personal agency in the caregiving role was a significant factor, as improved self-efficacy mediated 11-week depression symptoms with an indirect effect of -0.95 (SE = 0.32, 95% CI [-1.60, -0.36]). By isolating these mediation effects, the researchers have clarified that the intervention's efficacy is rooted in its ability to bolster the caregiver's internal psychological framework rather than simply providing general social support.

References

1. Yuan P, Xu Q, Zhu J, et al. A qualitative systematic review protocol to examine the experiences and needs of informal caregivers of patients with glioma.. Annals of palliative medicine. 2021. doi:10.21037/apm-21-1556

2. Reblin M, Ketcher D, McCormick R, et al. A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumor.. BMC health services research. 2021. doi:10.1186/s12913-021-06372-w

3. Ford E, Catt S, Chalmers AJ, Fallowfield L. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro-Oncology. 2012. doi:10.1093/neuonc/nor229

4. Forst D, Podgurski AF, Strander S, et al. Telehealth-based psychological intervention for caregivers of patients with primary malignant brain tumors: A randomized controlled trial.. Journal of Clinical Oncology. 2023. doi:10.1200/jco.2023.41.16_suppl.12008

5. Forst DA, Podgurski AF, Strander SM, et al. NeuroCARE: A Randomized Controlled Trial of a Psychological Intervention for Caregivers of Patients With Primary Malignant Brain Tumors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024. doi:10.1200/JCO.24.00065

6. Willis KD, Horick NK, Strander SM, et al. QOL-31. RESULTS OF A TELEHEALTH-BASED PSYCHOLOGICAL INTERVENTION FOR CAREGIVERS OF PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMORS: A MODERATION ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. Neuro-Oncology. 2024. doi:10.1093/neuonc/noae165.1066

7. Forst DA, Willis KD, Strander SM, et al. Coping in caregivers of patients with primary malignant brain tumors: A mediation analysis of a randomized controlled trial.. Journal of Clinical Oncology. 2024. doi:10.1200/jco.2024.42.16_suppl.12110